EXEL vs WELL · P/E 17, rev $1.24B vs P/E 100, rev $10.84B
Exelixis Inc (EXEL) versus Welltower Inc (WELL) — a side-by-side from cached financials, not a winner call.
Exelixis Inc (EXEL) is a biotechnology company listed on US.
Welltower Inc (WELL) is a reit - healthcare facilities company listed on NYSE.
Latest reported EXEL revenue for 2026-07-03 was $1.24B. Net income was $422.5M. EXEL currently screens at market cap $12.69B and trailing P/E 16.7.
Latest reported WELL revenue for 2025-12-31 was $10.84B. Net income was $936.8M. Revenue was up 35.6% from 2024-12-31 to 2025-12-31. WELL currently screens at market cap $145.81B and trailing P/E 99.8.
EXEL currently screens at market cap $12.69B and trailing P/E 16.7. WELL currently screens at market cap $145.81B and trailing P/E 99.8.
Not investment advice. Open the EXEL and WELL stock pages for the full models.
Not investment advice.